ARV-766
Products
Description
Luxdegalutamide (ARV-766) is an orally active and potent degrader of proteolysis targeting chimera (PROTAC) protein. ARV-766 degrades wild-type androgen receptor (AR) but also relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations.
Specifications
| Manufacturer Cat# | E1573 |
|---|---|
| Target | PROTAC |